Cellectis (CLLS) EBT (2015 - 2026)

Cellectis' EBT history runs 12 years deep, the most recent figure standing at -$8.8 million for Q1 2026.

• In Q1 2026, EBT fell 473.36% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$76.8 million (down 34.55% YoY), while the FY2025 annual figure was -$68.0 million, down 85.02% from the prior year.
• EBT for Q1 2026 stood at -$8.8 million, up from -$106.1 million in the prior quarter.
• The five-year high for EBT was $22.4 million in Q3 2025, with the low at -$106.1 million in Q4 2025.
• The 5-year median for EBT is -$8.8 million (2026), against an average of -$18.3 million.
• The sharpest annual moves came in 2023 and 2025: EBT slumped 3000.46% in 2023, then surged 191.03% in 2025.
• Cellectis' EBT stood at -$2.8 million in 2022, then plunged by 3000.46% to -$88.0 million in 2023, then soared by 52.63% to -$41.7 million in 2024, then sank by 154.56% to -$106.1 million in 2025, then jumped by 91.67% to -$8.8 million in 2026.
• Business Quant data shows CLLS's EBT at -$8.8 million in Q1 2026, -$106.1 million in Q4 2025, and $22.4 million in Q3 2025.